Drug repositioning (also referred to as drug repurposing), the process of finding new uses of existing drugs, has been gaining popularity in recent years. The availability of several established clinical drug libraries and rapid advances in disease biology, genomics and bioinformatics has accelerated the pace of both activity-based and in silico drug repositioning. Drug repositioning has attrac...

Neuroblastoma (NB) is the most common solid tumor in pediatric cases. NB accounts for about 8% of malignancies patients younger than 15 years, and since 50% newly diagnosed cases metastasize to regional lymph nodes, bone marrow, bone, liver, skin, disease usually its late stages. Overexpression N-MYC, which characterized by poor prognosis NB, changes progression course treatment. Targeting thes...

Anticancer drug development is facing increasingly challenge. Much more chemicals or bio-agents are required to be evaluated every year. High-quality and speediness of evaluation requires joint-efforts between chemists pharmacologists. This Editorial provides this area anticancer discovery, licensing.

The therapeutic safety of an anticancer drug is one of the most important concerns of the physician treating the cancer patient. Half maximal inhibitory concentration (IC50) and hillslope are usually used to represent the strength and sensitivity of an anticancer drug on cancer cells. The therapeutic safety of the anticancer drug can be assessed by comparing the IC50 and hillslope of anticancer...

The anticancer drug sensitivity of human cancers was tested by the human tumor clonogenic assay (HTCA). Of 152 human cancer specimens tested, 63 (41%) formed more than 30 tumor cell colonies in control plates and could be used to evaluate the drug sensitivity of tumor cells. In 42 (93%) of 45 clinical trials in 24 patients, a parallel correlation was observed between the in vitro anticancer dru...

Liposomes as pharmaceutical drug carriers were developed to increase antitumour efficacy and decrease drug toxicity. Doxorubicin HCl liposomal injection was the first liposomal encapsulated anticancer drug to receive clinical approval. To date, virtually all traditional anticancer drugs have been encapsulated in liposomes. The majority of clinical studies only support the concept of a decreased...

In this study, a simple strategy was described for the synthesis of Pt-SWCNTs conductive nanocomposite by microwave heated polyol method and nanocomposite characterized by EDS, FESEM, and XRD method. The Pt nanoparticles were decorated at the surface of SWCNTs with a diameter of 22.3 nm. The synthesized nanocomposite was used for modification of the carbon paste electrode (CPE) in the presence ...